Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung.
Saved in:
| Title: | Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. |
|---|---|
| Authors: | Wang, Daren1 (AUTHOR), Chang, Albert2,3 (AUTHOR), Shea, Fortune1,3 (AUTHOR), He, Yifei2,4 (AUTHOR), Spinney, Richard4,5 (AUTHOR), Whitsett, Jonathan D.1,6 (AUTHOR), Lahann, Joerg2,3,5,6,7 (AUTHOR), Mallery, Susan R.1,7 (AUTHOR) mallery.1@osu.edu |
| Source: | Pharmaceutics. Nov2025, Vol. 17 Issue 11, p1471. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189674187 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Wang%2C+Daren%22">Wang, Daren</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Albert%22">Chang, Albert</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shea%2C+Fortune%22">Shea, Fortune</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Yifei%22">He, Yifei</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spinney%2C+Richard%22">Spinney, Richard</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Whitsett%2C+Jonathan+D%2E%22">Whitsett, Jonathan D.</searchLink><relatesTo>1,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lahann%2C+Joerg%22">Lahann, Joerg</searchLink><relatesTo>2,3,5,6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mallery%2C+Susan+R%2E%22">Mallery, Susan R.</searchLink><relatesTo>1,7</relatesTo> (AUTHOR)<i> mallery.1@osu.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharmaceutics%22">Pharmaceutics</searchLink>. Nov2025, Vol. 17 Issue 11, p1471. 20p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189674187 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/pharmaceutics17111471 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 20 StartPage: 1471 Titles: – TitleFull: Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang, Daren – PersonEntity: Name: NameFull: Chang, Albert – PersonEntity: Name: NameFull: Shea, Fortune – PersonEntity: Name: NameFull: He, Yifei – PersonEntity: Name: NameFull: Spinney, Richard – PersonEntity: Name: NameFull: Whitsett, Jonathan D. – PersonEntity: Name: NameFull: Lahann, Joerg – PersonEntity: Name: NameFull: Mallery, Susan R. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 19994923 Numbering: – Type: volume Value: 17 – Type: issue Value: 11 Titles: – TitleFull: Pharmaceutics Type: main |
| ResultId | 1 |